{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260428568372/en/BREZTRI-approved-in-the-US-for-asthma-as-first-and-only-triple-therapy-for-patients-12-years-of-age-and-older", "message": "News view counter 684751 successfully enlarged"}